13F COMBINATION REPORT
Nan Fung Group Holdings Ltd
Quarter ended Q4 2023 · Filed November 13, 2023 · Accession 0001012975-23-000456
Total Value
$123.5M
Positions
39
Other Managers
2
Confidential Omitted
No
Holdings (39)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | KARUNA THERAPEUTICS INC | 48576A100 | 225,688 | $38.2M | 30.90% |
| 2 | ILLUMINA INC | ILMN | 119,196 | $16.4M | 13.25% |
| 3 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 368,665 | $12.1M | 9.78% |
| 4 | SEAGEN INC | SE | 47,096 | $10.0M | 8.09% |
| 5 | OCULIS HOLDING AG | OCSAW | 606,684 | $6.7M | 5.40% |
| 6 | SOMALOGIC INC | 83444K105 | 1,696,558 | $4.1M | 3.28% |
| 7 | EXSCIENTIA PLC | 30223G102 | 859,892 | $3.9M | 3.15% |
| 8 | XENON PHARMACEUTICALS INC | XENE | 106,680 | $3.6M | 2.95% |
| 9 | MERUS N V | N5749R100 | 137,038 | $3.2M | 2.62% |
| 10 | REPLIMUNE GROUP INC | REPL | 184,739 | $3.2M | 2.56% |
| 11 | KALVISTA PHARMACEUTICALS INC | KALV | 234,573 | $2.3M | 1.83% |
| 12 | BEIGENE LTD | BEIGF | 12,022 | $2.2M | 1.75% |
| 13 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 182,280 | $2.1M | 1.69% |
| 14 | INCYTE CORP | INCY | 32,022 | $1.8M | 1.50% |
| 15 | GERON CORP | GERN | 753,550 | $1.6M | 1.29% |
| 16 | EXELIXIS INC | EXEL | 64,200 | $1.4M | 1.14% |
| 17 | BOLT BIOTHERAPEUTICS INC | BOLT | 1,166,952 | $1.2M | 0.98% |
| 18 | PACIFIC BIOSCIENCES CALIF IN | 69404D108 | 136,655 | $1.1M | 0.92% |
| 19 | RANI THERAPEUTICS HLDGS INC | RANI | 493,584 | $1.1M | 0.87% |
| 20 | RHYTHM PHARMACEUTICALS INC | RYTM | 40,070 | $918,605 | 0.74% |
| 21 | ENTRADA THERAPEUTICS INC | TRDA | 49,082 | $775,496 | 0.63% |
| 22 | CABALETTA BIO INC | CABA | 47,150 | $717,623 | 0.58% |
| 23 | ARGENX SE | ARGX | 1,430 | $703,031 | 0.57% |
| 24 | AEROVATE THERAPEUTICS INC | 008064107 | 47,936 | $650,492 | 0.53% |
| 25 | ACADIA PHARMACEUTICALS INC | ACAD | 29,984 | $624,867 | 0.51% |
| 26 | BIOMEA FUSION INC | BMEA | 40,000 | $550,400 | 0.45% |
| 27 | DBV TECHNOLOGIES S A | DBVTF | 370,950 | $504,492 | 0.41% |
| 28 | ATHIRA PHARMA INC | 04746L104 | 180,000 | $363,600 | 0.29% |
| 29 | EARGO INC | 270087208 | 147,904 | $321,100 | 0.26% |
| 30 | BIOMARIN PHARMACEUTICAL INC | BMRN | 3,615 | $319,855 | 0.26% |
| 31 | AKERO THERAPEUTICS INC | 00973Y108 | 4,425 | $223,817 | 0.18% |
| 32 | ALX ONCOLOGY HLDGS INC | ALXO | 41,950 | $201,360 | 0.16% |
| 33 | AFFIMED N V | N01045108 | 372,472 | $178,004 | 0.14% |
| 34 | BIOCRYST PHARMACEUTICALS INC | BCRX | 17,847 | $126,357 | 0.10% |
| 35 | GALERA THERAPEUTICS INC | GRTX | 613,223 | $107,375 | 0.09% |
| 36 | ABCELLERA BIOLOGICS INC | ABCL | 12,521 | $57,597 | 0.05% |
| 37 | FIBROGEN INC | 31572Q808 | 62,106 | $53,591 | 0.04% |
| 38 | KODIAK SCIENCES INC | KOD | 19,622 | $35,320 | 0.03% |
| 39 | CERUS CORP | CERS | 14,172 | $22,959 | 0.02% |